FDA Classifies Diversatek SafeGuide Guidewire Recall Class 2

November 22, 2026
3 mins read
Two flexible endoscopes hang from a wall-mounted storage rack, with their control heads at the top and insertion tubes hanging down.
Flexible endoscopes hang in a storage rack in an endoscopy setting. The recalled Diversatek SafeGuide guidewires are used with esophageal dilators in procedures that depend on this kind of equipment. (Photo: Galenus Medical / Wikimedia Commons, CC BY-SA 4.0)
The Diversatek SafeGuide guidewire recall covers two models that clinics and hospitals should check for: model 1214-02, lot 244736, and model 1214-02D, lots 245290 and 245321. The FDA classified both listings as Class 2. Together, they cover 3,324 units distributed nationwide. Diversatek asked consignees to discard affected units after reporting that guidewires from the affected lots were more flexible than expected. The FDA posted both listings on November 20, 2026, under event ID 100170. Model 1214-02 is listed as recall Z-0515-2027; model 1214-02D is listed as Z-0516-2027. The firm initiated the recalls on October 5, 2026, and both FDA listings show the status as open and classified. The SafeGuide Marked Spring Tip Guidewire is used with esophageal dilators during dilation procedures. Diversatek says its SafeGuide products support esophageal dilation and reprocessing workflows, and its product information lists measurement bands at 20 cm increments and a 210 cm length for both recalled models. The manufacturer describes the spring tip as built to flex when it meets resistance.

Products and next steps

The FDA lists both products as esophageal dilators under product code KNQ, with 510(k) number K924646. Diversatek Healthcare, based in Milwaukee, Wisconsin, is the recalling firm.
IdentifierModel 1214-02Model 1214-02D
Lot number244736245290, 245321
UDI/DI0081673402097500816734021507
Recall numberZ-0515-2027Z-0516-2027
Quantity in commerce228 units3,096 units
Case quantity2 per case6 per case
Diversatek’s product information describes model 1214-02 as reusable and model 1214-02D as disposable; the FDA recall listings describe both as reusable. Facilities should check inventory, purchasing records and storage areas for both models and all three lot numbers. If stock matches, follow the firm’s instruction to discard it. Procurement teams can match the UDI/DI numbers in the table against supplier records and device labels. The FDA listing gives Laura L. Boll as the contact at 414-755-4806. Share the recall notice and identifiers with staff responsible for purchasing and device handling. The FDA recall entries do not report adverse-event counts or establish how many, if any, patients were affected. The stated reason is: “Guidewires from the affected lots are more flexible than expected.” The FDA records the cause as component design or selection but gives no further detail about the difference in flexibility or specific patient outcomes. The FDA defines Class II as a recall where use may cause temporary or medically reversible health consequences, or where the probability of serious consequences is remote. The classification alone does not report that a particular patient was harmed. Both listings remain open, which means the manufacturer has started the recall and not all affected products have been corrected or removed. See the FDA’s medical device recall information page and Enforcement Reports portal.
Hessian sandbags stacked as a defensive flood barrier around buildings
Previous Story

Sandbags vs. Flood Barriers: Which Could Better Protect Your Home?

Portrait of broadcaster Jonathan Dimbleby seated at a public discussion event
Next Story

Dimbleby rejects Spencer Diana death claims as grotesque

Latest from Health

Don't Miss